NexgenRx Inc.
NXG.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.44% | 1,964.47% | -118.01% | 369.53% | -93.19% |
| Total Depreciation and Amortization | 6.67% | 146.91% | -305.37% | -3.57% | -0.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.78% | -102.84% | 3,362.89% | -161.01% | 323.94% |
| Change in Net Operating Assets | 182.78% | 5.37% | -52.44% | -148.88% | 148.88% |
| Cash from Operations | 205.98% | 42.85% | 77.14% | -86.96% | 290.73% |
| Capital Expenditure | -687.76% | -15.05% | -267.86% | 75.11% | -64.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.73% | 76.09% | -310.53% | 53.31% | -200.00% |
| Cash from Investing | -311.41% | 66.70% | -305.68% | 57.54% | -158.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -9.68% | -16.98% | -9.96% | -16.43% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1,121.30% | 68.41% | -200.83% | 91.46% | -1,056.33% |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | -553.96% | 34.59% | -224.55% | 92.69% | -668.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.21% | 233.33% | -486.38% | -92.16% | 185.70% |